HomeAboutRankingsData Sources
ยฉ 2026 GeneE
๐Ÿงฌ
GeneE
50 sources retrieved ยท Most recent: April 2026 ยท Index updated 14 days ago
โ“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CFTR
CF transmembrane conductance regulator
Chromosome 7 ยท 7q31.2
NCBI Gene: 1080Ensembl: ENSG00000001626.19HGNC: HGNC:1884UniProt: P13569
1,945PubMed Papers
22Diseases
13Drugs
1,482Pathogenic Variants
FUNCTIONAL ROLE
Ion ChannelTransporter
RESEARCH IMPACT
Highly StudiedVariant-Rich
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
โœ“ Experimental GO Evidenceโœ“ Swiss-Prot Reviewed
cytoplasmchloride channel activityearly endosomeendoplasmic reticulum membranecystic fibrosiscongenital bilateral aplasia of vas deferens from CFTR mutationhereditary chronic pancreatitisbronchiectasis with or without elevated sweat chloride 1
โœฆAI Summary

CFTR is an ATP-binding cassette transporter that uniquely functions as an ion channel on epithelial cell membranes 1. Its primary function is regulating epithelial ion and water transport through chloride-selective anion conductance 2. CFTR mediates chloride ion transport across the cell membrane using ATP hydrolysis to gate channel opening, with the regulatory (R) domain blocking the intracellular vestibule until PKA phosphorylation enables channel activity 1. The channel is also permeable to bicarbonate, with selectivity depending on extracellular chloride concentration 34. Beyond direct ion transport, CFTR modulates other ion channels and transporters, including inhibition of the epithelial sodium channel (ENaC) and regulation of bicarbonate transporters 567. Clinically, CFTR dysfunction causes cystic fibrosis, the most common lethal genetic disease in Caucasians, resulting from impaired airway fluid homeostasis and compromised pathogen defense 28. The most prevalent mutation is ฮ”F508, occurring in ~70% of CF alleles in Northern Europe and North America 9. CFTR mutations also cause congenital bilateral absence of the vas deferens and infertility through disrupted epididymal electrolyte secretion essential for sperm maturation 10. Understanding CFTR's structural basis for channel function, distinct from other ABC transporters, is crucial for developing targeted therapeutics.

Sources cited
1
CFTR regulates epithelial ion and water transport, maintains airway fluid homeostasis, and contributes to pathogen defense
PMID: 26823428
2
CFTR structure reveals R domain blocking channel opening, with PKA phosphorylation enabling activation; distinguishing helix-loop transition in TM8 underlies channel function
PMID: 28340353
3
CFTR is permeable to bicarbonate with chloride-dependent selectivity
PMID: 15010471
4
CFTR bicarbonate permeability depends on extracellular chloride concentration
PMID: 19019741
5
CFTR inhibits ENaC channel activity and modulates its cell surface expression
PMID: 17182731
6
CFTR regulates ENaC complex activity and cell surface expression
PMID: 27941075
7
CFTR may regulate bicarbonate secretion by modulating SLC4A7 transporter
PMID: 12403779
8
CFTR plays important role in airway fluid homeostasis and pathogen defense
PMID: 16645176
9
CFTR gene located at 7q31, contains 27 exons; ฮ”F508 mutation occurs in ~70% of CF alleles in Northern Europe/North America
PMID: 1281033
10
CFTR mutations cause congenital bilateral absence of vas deferens and impaired sperm quality through disrupted epididymal electrolyte secretion
PMID: 9542966
Disease Associationsโ“˜22
cystic fibrosisOpen Targets
0.91Strong
congenital bilateral aplasia of vas deferens from CFTR mutationOpen Targets
0.83Strong
hereditary chronic pancreatitisOpen Targets
0.71Strong
bronchiectasis with or without elevated sweat chloride 1Open Targets
0.70Moderate
congenital bilateral absence of vas deferensOpen Targets
0.64Moderate
bronchiectasisOpen Targets
0.62Moderate
chronic pancreatitisOpen Targets
0.58Moderate
DiarrheaOpen Targets
0.55Moderate
Obstructive azoospermiaOpen Targets
0.54Moderate
acute lung injuryOpen Targets
0.53Moderate
cholestasisOpen Targets
0.47Moderate
familial atypical multiple mole melanoma syndromeOpen Targets
0.43Moderate
partial chromosome Y deletionOpen Targets
0.42Moderate
pancreatitisOpen Targets
0.41Moderate
genetic disorderOpen Targets
0.38Weak
coronary artery diseaseOpen Targets
0.37Weak
respiratory system diseaseOpen Targets
0.37Weak
ciliopathyOpen Targets
0.37Weak
kidney diseaseOpen Targets
0.35Weak
Recurrent pancreatitisOpen Targets
0.34Weak
Congenital bilateral absence of the vas deferensUniProt
Cystic fibrosisUniProt
Pathogenic Variants1,482
NM_000492.3(CFTR):c.1521_1523del (p.Phe508del)Pathogenic
Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1, modifier of|not provided|Hereditary pancreatitis|Duodenal stenosis|Recurrent pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|ivacaftor / tezacaftor response - Efficacy|ivacaftor / lumacaftor response - Efficacy|Obstructive azoospermia|CFTR-related disorder|See cases|Cystic fibrosis;Hereditary pancreatitis|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 508
NM_000492.4(CFTR):c.579+1G>TPathogenic
Cystic fibrosis|not provided|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.1657C>T (p.Arg553Ter)Pathogenic
Cystic fibrosis|not provided|not specified|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 553
NM_000492.4(CFTR):c.2657+5G>APathogenic
Cystic fibrosis|not specified|not provided|Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Respiratory ciliopathies including non-CF bronchiectasis
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.1624G>T (p.Gly542Ter)Pathogenic
Cystic fibrosis|not provided|Hereditary pancreatitis|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 542
NM_000492.3(CFTR):c.3718-2477C>TPathogenic
Cystic fibrosis|not specified|not provided|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|Hereditary pancreatitis
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.350G>A (p.Arg117His)Pathogenic
Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|ivacaftor response - Efficacy|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Obstructive azoospermia|Bronchiectasis with or without elevated sweat chloride 1|Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis|Respiratory ciliopathies including non-CF bronchiectasis
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 117
NM_000492.4(CFTR):c.254G>A (p.Gly85Glu)Pathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 85
NM_000492.4(CFTR):c.1000C>T (p.Arg334Trp)Pathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 334
NM_000492.4(CFTR):c.3909C>G (p.Asn1303Lys)Pathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Spermatogenic failure, Y-linked, 2|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 1303
NM_000492.4(CFTR):c.1040G>C (p.Arg347Pro)Pathogenic
Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 347
NM_000492.4(CFTR):c.1766+1G>APathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.1364C>A (p.Ala455Glu)Pathogenic
Cystic fibrosis|ivacaftor response - Efficacy|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 455
NM_000492.4(CFTR):c.3846G>A (p.Trp1282Ter)Pathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 1282
NM_000492.4(CFTR):c.489+1G>TPathogenic
Cystic fibrosis|not provided|Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Familial pancreatic carcinoma|Respiratory ciliopathies including non-CF bronchiectasis
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.2988+1G>APathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis diagnostic test
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.1516ATC[1] (p.Ile507del)Pathogenic
Cystic fibrosis|not provided|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 507
NM_000492.4(CFTR):c.1679G>C (p.Arg560Thr)Pathogenic
Cystic fibrosis|not provided|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 560
NM_000492.4(CFTR):c.1585-1G>APathogenic
Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004
NM_000492.4(CFTR):c.1652G>A (p.Gly551Asp)Pathogenic
Cystic fibrosis|Hereditary pancreatitis|not provided|ivacaftor response - Efficacy|Cystic fibrosis;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1
โ˜…โ˜…โ˜…โ˜…2004โ†’ Residue 551
View on ClinVar โ†—
Drug Targets13
BAMOCAFTORPhase III
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
CROFELEMERApproved
Anoctamin-1 blocker
Diarrhea
DEUTIVACAFTORApproved
Cystic fibrosis transmembrane conductance regulator activator
cystic fibrosis
ELEXACAFTORApproved
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
GALICAFTORPhase II
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
ICENTICAFTORPhase II
Cystic fibrosis transmembrane conductance regulator activator
chronic obstructive pulmonary disease
IOWH-032Phase II
Cystic fibrosis transmembrane conductance regulator inhibitor
Diarrhea
IVACAFTORApproved
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
LUMACAFTORApproved
Cystic fibrosis transmembrane conductance regulator stabiliser
cystic fibrosis
NAVOCAFTORPhase II
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
OLACAFTORPhase II
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
TEZACAFTORApproved
Cystic fibrosis transmembrane conductance regulator positive modulator
acute lung injury
VANZACAFTORApproved
Cystic fibrosis transmembrane conductance regulator positive modulator
cystic fibrosis
Related Genes
GOPCProtein interaction99%HSPA8Protein interaction99%HSP90AA1Protein interaction99%PRKACAProtein interaction98%RNF5Protein interaction98%PRKACGProtein interaction98%
Tissue Expression6 tissues
Liver
100%
Lung
89%
Ovary
19%
Brain
16%
Heart
7%
Bone Marrow
2%
Gene Interaction Network
Click a node to explore
CFTRGOPCHSPA8HSP90AA1PRKACARNF5PRKACG
PROTEIN STRUCTURE
Preparing viewerโ€ฆ
PDB2PZE ยท 1.70 ร… ยท X-ray
View on RCSB โ†—
Constraintโ“˜
LOEUFโ“˜
1.15LoF Tolerant
pLIโ“˜
0.00Tolerant
Observed/Expected LoF0.99 [0.85โ€“1.15]
RankingsWhere CFTR stands among ~20K protein-coding genes
  • #58of 20,598
    Most Researched1,945 ยท top 1%
  • #201of 1,025
    FDA-Approved Drug Targets7 ยท top quartile
  • #18of 5,498
    Most Pathogenic Variants1,482 ยท top 1%
  • #12,005of 17,882
    Most Constrained (LOEUF)1.15
Genes detectedCFTR
Sources retrieved50 papers
Response timeโ€”
๐Ÿ“„ Sources
50โ–ผ
1
Molecular Structure of the Human CFTR Ion Channel.
PMID: 28340353
Cell ยท 2017
1.00
2
Editorial.
PMID: 32172929
Arch Pediatr ยท 2020
0.90
3
Recovery of ฮ”F508-CFTR Function by Citrate.
PMID: 36296967
Nutrients ยท 2022
0.88
4
CFTR Modulators for the Gastroenterologist.
PMID: 37548477
J Pediatr Gastroenterol Nutr ยท 2023
0.86
5
Commentary for the article: MicroRNA-1246 regulates proliferation, invasion and differentiation in human vascular smooth muscle cell by targeting cystic fibrosis transmembrane conductance regulator (CFTR).
PMID: 33452915
Pflugers Arch ยท 2021
0.84